ARHS
Arhaus, Inc.
ARHS has a slight edge over BABA overall, supported by stronger fundamentals.
BABA
Alibaba Group Holding Limited
BABA has lower modeled downside risk, despite its lower overall score.
ARHS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
ARHS's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
ARHS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $4.81 | -64% |
| Fair | 18x | $8.20 | -39% |
| Expensive | 22x | $10.24 | -24% |
| Forward | 24x | $13.52 | — |
| Current | 29x | $13.52 | — |
Historical ranges are pointers, not guarantees.
ARHS's PE is in its expensive range at 29x. If earnings grow as analysts expect, today's price would be 24x next year's earnings.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA has the edge over ARHS in the historical PE scenario, which offers more potential upside but is not a forecast.
ARHS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for ARHS, with profitability improving. However, they disagree widely on these estimates.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
ARHS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.56 | +22% |
| Q3 2026 | $0.46 | -12% |
| Q2 2026 | $0.50 | 0% |
| Q1 2026 | $0.47 | +15% |
| Q4 2025 | $0.48 | -2% |
| Q3 2025 | $0.52 | -7.1% |
| Q2 2025 | $0.50 | -21% |
| Q1 2025 | $0.41 | -46% |
| Q4 2024 | $0.49 | -45% |
ARHS's earnings per share have fallen from their peak: $0.46 over the past year, against $1.13 in mid-2023.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over ARHS on earnings, with more consistent year-over-year improvement.
ARHS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $368.1M | +6.8% |
| Q2 2026 | $384.9M | +7.4% |
| Q1 2026 | $314.3M | +0.9% |
| Q4 2025 | $364.8M | +5.1% |
| Q3 2025 | $344.6M | +8% |
| Q2 2025 | $358.4M | +16% |
| Q1 2025 | $311.4M | +5.5% |
| Q4 2024 | $347M | +0.9% |
ARHS has the edge over BABA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.7% | -2 points |
| Q2 2026 | 14% | +1 points |
| Q1 2026 | 0.7% | -1.1 points |
| Q4 2025 | 5.5% | -2.7 points |
| Q3 2025 | 4.8% | +1.4 points |
| Q2 2025 | 13% | +3.6 points |
| Q1 2025 | 1.7% | -4.5 points |
| Q4 2024 | 8.2% | -3.7 points |
ARHS's operating margin was 2.7% last quarter, down 2 points from the same quarter a year ago.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over ARHS on profitability, with a higher operating margin.
ARHS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $91.9M | +228% |
| Q2 2026 | $48.3M | +131% |
| Q1 2026 | -$26.6M | -241% |
| Q4 2025 | -$8.8M | -168% |
| Q3 2025 | $28M | +509% |
| Q2 2025 | $20.9M | +86% |
| Q1 2025 | $18.9M | +73% |
| Q4 2024 | $13M | +$26.8M |
ARHS has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
ARHS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +467K shares |
| 1 year | +0.4% | +598K shares |
| 3 years | +1.5% | +2.1M shares |
| 5 years | +27% | +30.2M shares |
| Available history | +401% | +114M shares |
ARHS has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | $50,000 |
| Q1 2020 | $50,000 |
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
ARHS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.3x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -1.8x | Net Cash |
| Q2 2025 | -1.7x | Net Cash |
| Q1 2025 | -1.9x | Net Cash |
| Q4 2024 | -1.6x | Net Cash |
ARHS has the edge over BABA on leverage, with a lower net debt burden relative to earnings.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
ARHS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.0 | Neutral |
| Stochastic | 90.6 | Overbought |
ARHS's weekly RSI is 69 (neutral) and its Stochastic is 91 (overbought).
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
ARHS PE vs Consumer Cyclical Sector
| Metric | ARHS | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 18x | 63% above |
| PE % | 96 | 56 | 40 pts above |
ARHS is trading at 29x earnings, a 63% premium to the Consumer Cyclical sector's median of 18x.
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA has the edge over ARHS on valuation relative to its sector.
ARHS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.4 | 18% above |
| 20 week MA | $9.67 | 40% above |
| 50 week MA | $8.97 | 51% above |
| 100 week MA | $9.41 | 44% above |
| 200 week MA | $10.5 | 29% above |
ARHS has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
ARHS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $12.2 | $10.4 | -15% |
| 2022 | $10.4 | $9.24 | -11% |
| 2023 | $9.24 | $11.9 | +28% |
| 2024 | $11.9 | $9.26 | -22% |
| 2025 | $9.26 | $11.7 | +27% |
| 2026 YTD | $11.7 | $13.5 | +15% |
ARHS has the edge over BABA on returns for 2026, with the stronger performance.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.